Skip to search formSkip to main contentSkip to account menu

lorglumide

Known as: 4-((3,4-dichlorobenzoyl)amino)-5-(dipentylamino)-5-oxopentanoic acid 
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

CR 1409

Broader (2)

Hormone AntagonistsProglumide
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Plasminogen activator inhibitor (PAI)-1 suppresses inhibition of gastric emptying by cholecystokinin (CCK) in mice☆
Review
2010
Review
2010
Brain-gut axis in the modulation of pancreatic enzyme secretion.
Pancreatic enzyme secretion is controlled by complex of neurohormonal mechanisms, activated by nutrients. Food components in the… 
2008
2008
Activation of cholecystokinin (CCK 1) and serotonin (5-HT 3) receptors increases the discharge of pancreatic vagal afferents.
Highly Cited
2006
Highly Cited
2006
Feeding-dependent depression of melanin-concentrating hormone and melanin-concentrating hormone receptor-1 expression in vagal afferent neurones
2005
2005
Cholecystokinin1 receptors mediate the increase in Fos-like immunoreactivity in the rat myenteric plexus following intestinal oleate infusion
2003
2003
Effect of Dai-kenchu-to (Da-Jian-Zhong-Tang) on the delayed intestinal propulsion induced by chlorpromazine in mice.
1995
1995
Involvement of different subtypes of cholecystokinin receptors in opioid antinociception in the mouse
1991
1991
Effects of bombesin on the development of N-nitrosobis(2-oxopropyl)amine-induced pancreatic lesions in hamsters.
1989
1989
Study into the role of cholecystokinin in bombesin-stimulated pancreatic growth in rats and hamsters.
1989
1989
Evidence for an involvement of substance P, but not cholecystokinin-like peptides, in hexamethonium-resistant intestinal peristalsis
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)